Morning Shine Pharma specializes in the supply of upstream core raw materials and biotechnology products for peptide, XDC, and nucleic acid therapeutics. We also provide custom chemical synthesis and CMO services, supporting projects from early development through GMP manufacturing.

Our portfolio includes industry-leading monodispersed PEGs and derivatives, with PEG24 homolog impurities controlled below 0.15%, enabling improved performance in ADC, peptide, and oligonucleotide drug development.

We are also a leading supplier of peptide side chains and short peptides, with the largest production capacity for side chains and short peptides in China, high quality standards, and GMP-compliant manufacturing.

In the field of nucleic acid therapeutics, we offer high-quality GalNAc and Unylinker, with GalNAc purity above 99% and single impurities below 0.10%.

Our core competencies include advanced synthesis of complex and highly modified compounds, high-resolution separation and purification technologies, and comprehensive quality research aligned with global regulatory standards.